Your browser doesn't support javascript.
loading
Trametinib for patients with recurrent low-grade serous ovarian cancer: A cost-effectiveness analysis.
Piao, Huiling; Wu, Meiyu; Qin, Shuxia; Tang, Zhiyao; Zhou, Guangliang; Wan, Xiaomin; Zuo, Xiaocong.
Afiliación
  • Piao H; Department of Pharmacy, Third Xiangya Hospital, Central South University, Changsha 410013, China.
  • Wu M; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Qin S; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Tang Z; Department of Pharmacy, Third Xiangya Hospital, Central South University, Changsha 410013, China.
  • Zhou G; Department of Pharmacy, Third Xiangya Hospital, Central South University, Changsha 410013, China.
  • Wan X; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Electronic address: wanxiaomin@csu.edu.cn.
  • Zuo X; Department of Pharmacy, Third Xiangya Hospital, Central South University, Changsha 410013, China. Electronic address: zuoxc08@126.com.
Gynecol Oncol ; 168: 17-22, 2023 01.
Article en En | MEDLINE | ID: mdl-36368128
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Análisis de Costo-Efectividad Tipo de estudio: Health_economic_evaluation Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Análisis de Costo-Efectividad Tipo de estudio: Health_economic_evaluation Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos